XML 52 R41.htm IDEA: XBRL DOCUMENT v3.24.3
EQUITY METHOD INVESTMENTS (Details Narrative)
3 Months Ended 9 Months Ended
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2024
CAD ($)
Sep. 30, 2024
EUR (€)
Sep. 30, 2023
USD ($)
Dec. 31, 2023
USD ($)
Gain on extinguishment of debt $ 0 $ 706 $ 0     $ 1,911,476  
Cosmo Farmacy LP [Member]              
Initial share capital | €         € 150,000    
Initial share capital increased | €         500,000    
Pharmacy license value | €         € 350,000    
Maturity period of license     30 years 30 years 30 years    
Ownership equity 70.00%   70.00%        
Cash contributed to limited partner | €         € 150,000    
Equity ownership remaining 30.00%   30.00%        
Marathon Global Inc [Member] | Distribution and Equity Acquisition Agreement [Member]              
Upfront cash received       $ 2,000,000      
Fair value of settlement account     $ 1,554,590        
Gain on extinguishment of debt     $ 1,554,590        
Agreement term     five (5) years five (5) years five (5) years    
Cash received upon gross sales       $ 2,750,000      
Marathon Global Inc [Member] | Distribution and Equity Acquisition Agreement [Member] | Gross Sales One [Member]              
Cash received upon gross sales       2,750,000      
Gross sales       13,000,000      
Marathon Global Inc [Member] | Distribution and Equity Acquisition Agreement [Member] | Gross Sales [Member]              
Cash received upon gross sales       2,750,000      
Gross sales       $ 6,500,000      
Share Exchange Agreement [Member] | ICC [Member]              
Investement $ 167,175   $ 167,175       $ 165,930